ArticleProstate cancer and prostatic diseases2025

The appropriateness of PSMA PET/CT in newly diagnosed unfavorable intermediate-risk prostate cancer patients-towards a tumor volume-based risk stratification.

Marinus J Hagens et al.PubMed ↗Publisher ↗

No numbers read from the abstract.